- Post-operative massage improves short-term pain scores although objective outcome measures often not reported
- Music therapy reduces pain scores without reducing opioid consumption
- Patient education does not improve opioid consumption or pain scores whether performed pre- or post-operatively
Post-Sternotomy Pain
Post-Sternotomy Pain
Resources
- Pain management after cardiac surgery via median sternotomy (PROSPECT, EJA, 2023)
- Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (Critical Care Medicine, 2018)
- Evolving practice of perioperative pain management for cardiac surgery – patient-controlled analgesia, parasternal blocks, and beyond: a narrative experience from a regional centre (BJA, 2023)
- Pain after median sternotomy can be difficult to treat, and poorly controlled is associated with complications:
Sequelae of poor pain control after sternotomy |
Post-operative pulmonary complications |
Arrhythmias |
MI or other cardiac complications |
Impaired wound healing |
Prolonged length of stay |
Chronic post-sternotomy pain syndrome (a form of CPSP) |
Paracetamol
- Use associated with improvement pain scores ± reduction in opioid consumption vs. placebo
- Should be regularly used in the pre-, intra- and post-operative periods
NSAIDs
- NSAIDs are recommended for pre- or intra-operative use, where not contraindicated, in combination with paracetamol
- Evidence suggests low risk of AKI, cardiac adverse events or significant bleeding with short duration of use
- In our CICU, 100mg rectal diclofenac is administered prior to extubation
- COX-2 specific inhibitors are not recommended by PROSPECT guidance
Opioids
- No evidence to support use of one opioid over any other
- Should generally be reserved as rescue analgesia post-operatively
- In our CICU, regular dihydrocodeine is often used alongside PRN immediate release enteral opioid
NMDA antagonists
- Magnesium use is associated with reduced pain scores and opioid requirements
- Optimal dosing unclear; one study used 2g bolus followed by 2g/day
- No difference in pain score or opioid use from two studies where ketamine was used intraoperatively
- On this basis, not recommended by PROSPECT guidance
Dexmedetomidine
- Intra- or post-operative infusions may improve outcomes, reduce pain scores and opioid requirements
- Has negative cardiovascular effects (hypotension, bradycardia), which may preclude its use
- Optimal dosing unknown; one study infused 0.5 μg kg−1 h−1 from initiation of anaesthesia until tracheal extubation in ICU
Gabapentinoids
- Should be resumed in patients who are on the drugs long-term
- Not associated with shorter duration of extubation or length of ICU stay in two trials of pregabalin vs. placebo in cardiac surgery
- Quality of evidence of routine use after cardiac surgery is low; not recommended by PROSPCET guidance due to 'inconsistent procedure-specific evidence'
Others
- Lidocaine patches; often used for pain arising from chest drain sites or severe post-operative sternotomy pain, but not robustly evidence based
- Nefopam; may be used to reduce opioid consumption and opioid-related side effects, but not always available, itself has limiting side-effects and lacks robust evidence
- Entonox; sometimes used for chest drain or cardiac pacing wire removal, but not recommended by PADIS guidelines due to low quality evidence
Block | Advantages | Disadvantages |
Surgical site LA infusion | ↓ pain score ↓ opioid consumption |
|
Parasternal block | ↓ pain score ↓ opioid consumption Safe in anticoagulated patient |
|
Paravertebral block | Analgesia no better than TEA Debatable effect on pain score and opioid use |
|
Transversus thoracis plane block | ↓ pain score | No ↓ opioid consumption May be inappropriate if LIMA grafted |
Erector spinae block | ↓ pain score ↓ opioid consumption Non-inferior to TEA |
Limited evidence in cardiac surgery |
Thoracic epidural Intrathecal opioids |
↓ pain score ↓ opioid consumption |
Standard risks of neuraxial intervention
Meta-analyses don't show clear analgesic benefit No significant ↓ in POPC Safety concerns in anticoagulated patients |
Lidocaine infusions | No improvement in pain or organisational outcomes Lack of procedure-specific evidence |